CallidusCloud Announces Lightning Commissions on the Salesforce AppExchange, the World's Leading Enterprise Apps Marketplace
Sales professionals now benefit from access to commissions and incentive compensation information right in their Salesforce screens
DUBLIN, Calif., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Callidus Software Inc. (NASDAQ:CALD), a global leader in cloud-based sales, marketing, learning, and customer experience solutions, today announced it has launched its Lightning Commissions application on the Salesforce AppExchange, empowering businesses to connect with their customers, partners, and employees in entirely new ways.
Lightning Commissions provides cutting-edge visibility for sales reps into the entire sales process and includes tools to easily estimate commissions payments under different scenarios. The offering is available in the Lightning or Classic versions of Salesforce and runs on desktops or mobile devices.
CallidusCloud Lightning Commissions
With CallidusCloud Lightning Commissions, sales representatives can benefit from the following capabilities:
Review compensation plans and view real-time commission estimates for all opportunities, at all stages.
- Estimate and forecast commission payouts under different deal scenarios or with different discounts.
Sales operations can create reports and accurately adjust forecasts, allocate budgets, create promotions to spur new business, and change sales processes to maximize success. They can create and interact with reports from a single dashboard-instead of waiting for IT to create and integrate data -and drill down into attainment, performance, and payment details by sales representative, region, or product.
Increasing visibility into the compensation process and payouts with Lightning Commissions enables sales representatives to adjust behaviors at every stage of the sales cycle to maximize their income and an organization's revenue. As the opportunity changes, sales representatives can better understand the potential impact on their commissions. Granular visibility also minimizes compensation disputes, as sales representatives can see detailed breakdowns by product and opportunity in real time.
Lightning Commissions is delivered as part of the CallidusCloud Lead to Money suite, a SaaS suite designed to help businesses drive enterprise engagement, sales performance management, and sales effectiveness throughout the sales cycle with award-winning, multi-tenant cloud software.
"To be effective, sales incentives need to be well understood. Sales representatives need to know the effect different deal mixes and discounts would have on their payouts. Lightning Commissions provides quick access to this information, without the user needing to leave Salesforce," said Andres Botero, SVP and Chief Marketing Officer at CallidusCloud.
"Everyone and everything is getting smarter and more connected than ever before, and companies are looking to transform the way they connect with customers, partners and employees," said Kori O'Brien, SVP, ISV Sales, Salesforce. "By leveraging the power of the Salesforce Platform, CallidusCloud provides customers with an exciting new way to gain deeper insights into sales commissions and payouts."
About Salesforce AppExchange
Salesforce AppExchange is the world's leading enterprise apps marketplace that empowers companies to sell, service, market, and engage in entirely new ways. With 3,000 partner apps and more than 4 million customer installs, it is the most comprehensive source of cloud, mobile, social, IoT, analytics, and artificial intelligence technologies for businesses.
Like Salesforce on Facebook: http://www.facebook.com/salesforce
- Follow Salesforce on Twitter: https://twitter.com/salesforce
- Become a fan of CallidusCloud: https://www.facebook.com/CallidusSoftware
- Follow CallidusCloud on Twitter: https://twitter.com/CallidusCloud
Salesforce, AppExchange and others are among the trademarks of salesforce.com, inc.
Callidus Software Inc. (NASDAQ:CALD), doing business as CallidusCloud®, is a global leader in cloud-based sales, marketing, learning, and customer experience solutions. CallidusCloud enables organizations to accelerate and maximize their lead to money processes with a complete suite of solutions that identify the right leads, ensure proper territory and quota distribution, enable sales forces, automate configure price quote, speed up contract negotiations, and streamline sales compensation-driving bigger deals, faster. Approximately 5,700 leading organizations, across all industries, rely on the CallidusCloud Lead to Money suite to close more deals and make more money faster.
Twitter: @calliduscloud, @calliduscloudIR
©2017 Callidus Software Inc. All rights reserved. Callidus, Callidus Software, the Callidus Software logo, CallidusCloud, the CallidusCloud logo, Clicktools, SURVE, syncfrog, TrueComp Manager, ActekSoft, ACom3, iCentera, Webcom, Litmos, the Litmos logo, LeadFormix, Rapid Intake, 6FigureJobs, and LeadRocket are trademarks, service marks, or registered trademarks of Callidus Software Inc.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Callidus Software via Globenewswire
Följ NASDAQ OMX
Abonnera på våra pressmeddelanden.
Senaste pressmeddelandena från NASDAQ OMX
Novelion Therapeutics Announces Presentation of Positive Metreleptin Data at American Diabetes Association Scientific Sessions25.6.2018 14:00 | Pressmeddelande
Data Show Leptin Replacement Therapy Sustainably Decreased Weight Over Time in Patients with Low Baseline Leptin Levels Company plans to initiate Phase 2 proof of concept study in hypoleptinemic metabolic disorder (HMD) by year-end VANCOUVER, British Columbia, June 25, 2018 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing and commercializing therapies for individuals living with rare diseases, today announced that clinical data from a metreleptin study assessing weight loss in overweight and obese adults with low leptin levels will be featured in a poster presentation at the American Diabetes Association's (ADA) 78th Scientific Sessions, being held June 22-26, 2018 in Orlando. The study, titled "Efficacy of Metreleptin for Weight Loss in Overweight and Obese Adults With Low Leptin Levels," was conducted in adults with low baseline leptin, defined as <16 ng/mL in females and <5 ng/mL in males, and Body Mass Index (BMI) lev
Effnetplattformens intressebolag Earners Alliance genomför nyemission25.6.2018 10:00 | Pressmeddelande
Stockholm, 25 juni 2018 -- För att möjliggöra en internationell expansion genomför Earners Alliance Holding AB (publ), f.d. CasinoWilds Holding AB (publ), ("Earners Alliance") för närvarande en nyemission med företräde för sina befintliga aktieägare om cirka 10 MSEK före emissionskostnader. Teckningstiden pågår till och med den 6 juli 2018. Under 2019 planerar bolaget för en notering på Nasdaq First North, Nordic Growth Market eller Spotlight Stock Market. Emissionslikviden avses huvudsakligen att användas för försäljning och marknadsföring. Företrädesemissionen genomförs genom utgivande av teckningsrätter. Aktieägare erhåller en (1) teckningsrätt per befintlig aktie och erbjuds att för fem (5) teckningsrätter teckna två (2) nyemitterade aktier för 4,50 SEK per aktie. Anmälan av intresse om teckning av aktier utan stöd av företrädesrätt i företrädesemissionen sker genom att ifyllnad av särskild anmälningssedel. Effnetplattformen kommer att delta i nyemissionen. Mer information om Earne
ERYTECH Confirms Strategic Focus of Eryaspase on Solid Tumors and Ceases Development in Acute Lymphoblastic Leukemia25.6.2018 00:06 | Pressmeddelande
Conference call on Monday, June 25th at 2:30 pm CET/8:30 am EDT Focuses development efforts on solid tumor indications Confirms planned launch of company-sponsored randomized Phase 2 trial in first-line pancreatic cancer, in addition to ongoing launch of Phase 3 trial in second-line pancreatic cancer. Expands eryaspase production capacity in the United States and France Plans to cease development in acute lymphoblastic leukemia (ALL), including withdrawal of European Marketing Authorization Application (MAA) LYON, France and CAMBRIDGE Mass., June 24, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext:ERYP) (Nasdaq:ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that it will focus its development efforts for its product candidate eryaspase on the potential treatment of selected solid tumor indications. The company also announced that it plans to cease its development pro
CORRECTING and REPLACING -- PRESS ALERT & INVITATION: Arbitrade to Hold a Press Conference on June 28th From Bermuda - Its New Global Headquarters23.6.2018 14:00 | Pressmeddelande
NEW YORK, June 23, 2018 (GLOBE NEWSWIRE) -- In a press release issued under the same headline earlier today by Arbitrade, please note that the correct date of the event is Thursday, June 28, 2018 at 8:00 a.m. EDT. The corrected release follows: This is an invitation to all media following Arbitrade and/or covering the cryptocurrency markets. You are invited to join Arbitrade's Chairman, Len Schutzman, and management who will discuss their progress toward establishing Arbitrade as a world-class cryptocurrency exchange and coin company. They will also discuss their move and incorporation into Bermuda, one of the world's best regulated jurisdictions and a platform from which Arbitrade will reach out to several international markets. It will be a lively discussion that will also include details of the many economic and social advantages and new jobs that companies, like Arbitrade, will bring to countries in which they settle and do business around the world. Details of how to access the pr
15th Consecutive Nasdaq Closing Cross Sets Record for Number of Shares Traded During 2018 Russell US Indexes Reconstitution22.6.2018 23:19 | Pressmeddelande
NEW YORK, June 22, 2018 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq:NDAQ) today announced the Nasdaq Closing Cross had a record day as it was used for the 15th consecutive year to rebalance Nasdaq-listed securities in the entire family of Russell U.S. Indexes, part of leading global index provider FTSE Russell, during their annual reconstitution. A record 1.188 billion shares representing $39.26 billion were executed in the Closing Cross in 0.935 seconds across some 2,591 Nasdaq-listed stocks. This compares to 2017, when Nasdaq executed 972 million shares representing $28.9 billion executed in 0.861 seconds across 2,499 Nasdaq-listed stocks. "Today, we saw a record-breaking performance for the Nasdaq Closing Cross, which benefits issuers and investors alike with transparent and efficient price discovery," said Tom Wittman, Head of Global Equities and Executive Vice President of Global Trading and Market Services at Nasdaq. "The rebalance is an important event to ensure that the Russell U.S. ind
PRESS ALERT & INVITATION: Arbitrade to Hold a Press Conference on June 28th From Bermuda - Its New Global Headquarters22.6.2018 22:29 | Pressmeddelande
NEW YORK, June 22, 2018 (GLOBE NEWSWIRE) -- This is an invitation to all media following Arbitrade and/or covering the cryptocurrency markets. You are invited to join Arbitrade's Chairman, Len Schutzman, and management who will discuss their progress toward establishing Arbitrade as a world-class cryptocurrency exchange and coin company. They will also discuss their move and incorporation into Bermuda, one of the world's best regulated jurisdictions and a platform from which Arbitrade will reach out to several international markets. It will be a lively discussion that will also include details of the many economic and social advantages and new jobs that companies, like Arbitrade, will bring to countries in which they settle and do business around the world. Details of how to access the press briefing webcast are as follows: Please register now for the upcoming Arbitrade Conference Call: Date: Wednesday, June 27, 2018 Time: 8:00 a.m. EST We recommend that you connect to the meeting at l
I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.Besök vårt pressrum